CD33 and Alzheimer disease: Siglec-mediated inhibition on cellular uptake was also observed for CD33 (Siglec-3) which inhibits uptake and clearance of amyloid beta 42 by microglia and is implicated in exacerbation of Alzheimer’s disease [32, 33].